News

India is a major player in the global pharmaceutical sector, with the largest supply of non-patented medicines and providing 20% of the world’s generic drug exports. According to the “Indian Economic Survey 2021,” India’s pharmaceutical market was estimated at $42 billion in 2021, and it could triple over the next decade. India’s pharmaceutical industry is …

India’s Thriving Pharmaceutical Industry: R&D and Government Support Read More »

On March 21, the UK’s National Institute for Health and Clinical Excellence (NICE) released draft recommendations for the use of point-of-care testing to improve antimicrobial prescribing for urinary tract infections (UTIs). The potential benefits of rapid diagnostics have been highlighted, but further data on test accuracy is needed before they can be utilized in the …

Is it possible to determine the presence of uropathogens in urine in 40 minutes? Read More »

A recent UK nested case-control study and meta-analysis examined the association between combined and progestagen-only hormonal contraceptives and breast cancer risk. The study, which was published on March 21, 2023, found that there is a small but significant increased risk of breast cancer associated with the use of hormonal contraceptives. The researchers found that women …

Hormonal Contraceptives And Breast Cancer Risk Read More »

Antimicrobial resistance is largely driven by the overuse and misuse of antibiotics. However, the impact of other drugs in this process is often overlooked. Recently, Australian scientists conducted a study published in the journal PNAS showing that certain antidepressants, such as sertraline and duloxetine, can induce resistance in E. coli to various antibiotics. This highlights …

Antidepressants as a New Player in Antibiotic Resistance? Read More »

Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant) nasal spray for the acute treatment of migraine with or without aura in adults.   This is the first and only calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray. ZAVZPRET has been proven effective, tolerable, and safe in two …

Pfizer’s ZAVZPRET™ nasal migraine spray is the first to be approved by the FDA Read More »